Drawing for QIAENSEMBLE

USPTO serial 77679069

QIAENSEMBLE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
IM, JEAN H
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QIAENSEMBLE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Valerie Walsh Johnson

WENDY ROBERTSON BAKER, DONELSON, BEARMAN, CALDWELL & BER6060 POPLAR AVENUE, SUITE 440MEMPHIS, TN 38119UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; materials for columns in the nature of reagents and solvents for the purpose of sample preparation, purification, lysis, modification and manipulation of cells, none of the foregoing for medical or veterinary purposes; materials for columns in the nature of reagents and solvents for the marking, separation, isolation, purification, amplification and analysis of nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological materials for columns in the nature of reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells as well as for the marking, separation, isolation, purification, amplification, and analysis of nucleic acids, enzymes, proteins, macro molecules and biologically active substances, none of the foregoing for medical or veterinary purposesACTIVE—
005Products for medical and veterinary medical purposes, namely, diagnostic preparations in the nature of nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and diagnostic materials for columns, all for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products in the nature of reagents and solvents used for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, extracting genetic information and diagnosing conditions of the human body; Kits for medical and veterinary purposes comprised of chemical, biochemical and biotechnological products in the nature of reagents and solvents, all being used for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analysis of nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, extracting genetic information and diagnosing conditions of the human bodyACTIVE—
009Scientific apparatus, instruments and equipment for research and examination purposes, namely, columns for detecting nucleic acids, enzymes, and small molecules; automated laboratory equipment, namely, add-ons therefor, namely, preprogrammed smart cards for DNA purification protocols; laboratory equipment, namely, microplates, pipettes, pipette tips and pipette tip holders, sample containers, reagent holders, flasks, reagent tube holders, holders for micro containers, magnetic syringes, biochips for the purpose of screening large numbers of biological analytes, thermocyclers for the purpose of performing polymerase chain reactions or isothermal amplifications, homogenizers for the purpose of breaking up cell membranes and mixing the resulting liquids, all of the aforementioned being included in this class and being for scientific research and examination purposesACTIVE—
010Medical instruments for use in diagnosis and screening with reagants for sexually transmitted diseases, diseases caused by viruses, bacteria or fungi, diseases caused by bacteria with resistance to antibioticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 13, 2013MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 13, 2013ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 27, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 26, 2012EX5GSOU EXTENSION 5 GRANTED—
Sep 25, 2012NOACCORRECTED NOA E-MAILED—
Sep 25, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2012EXT5SOU EXTENSION 5 FILED—
Sep 24, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 22, 2012EX4GSOU EXTENSION 4 GRANTED—
Sep 22, 2012DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 22, 2012CORVREVIEW OF CORRESPONDENCE COMPLETE—
Sep 17, 2012INOAAMENDMENT AFTER NOA NOT ENTERED—
Sep 17, 2012DRRRDIVISIONAL REQUEST RECEIVED—
Sep 17, 2012FAXXFAX RECEIVED—
Sep 14, 2012FAXXFAX RECEIVED—
Sep 14, 2012FAXXFAX RECEIVED—
Aug 24, 2012IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Aug 24, 2012FAXXFAX RECEIVED—
Aug 10, 2012INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Jun 22, 2012IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Jun 22, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2012INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Apr 4, 2012EXT4SOU EXTENSION 4 FILED—
Apr 4, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 4, 2012ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 14, 2011EX3GSOU EXTENSION 3 GRANTED—
Sep 13, 2011EXT3SOU EXTENSION 3 FILED—
Sep 13, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 15, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 14, 2011EX2GSOU EXTENSION 2 GRANTED—
Mar 14, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 8, 2011EXT2SOU EXTENSION 2 FILED—
Mar 8, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 2, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 30, 2010EX1GSOU EXTENSION 1 GRANTED—
Sep 30, 2010EXT1SOU EXTENSION 1 FILED—
Sep 30, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 14, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 14, 2009ALIEASSIGNED TO LIE—
Nov 30, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 7, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 12, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 6, 2009DOCKASSIGNED TO EXAMINER—
Mar 4, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 3, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 2, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance